<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Morote, Juan</author>
      <author>Borque-Fernando, Ángel</author>
      <author>Esteban, Luis E.</author>
      <author>Picola, Natàlia</author>
      <author>Muñoz-Rodríguez, Jesús</author>
      <author>Paesano, Nahuel</author>
      <author>Ruiz-Plazas, Xavier</author>
      <author>Muñoz-Rivero, Marta V.</author>
      <author>Celma, Anna</author>
      <author>García-de Manuel, Gemma</author>
      <author>Miró, Berta</author>
      <author>Abascal, José M.</author>
      <author>Servian, Pol</author>
    </authors>
  </contributors>
  <titles>
    <title>Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia</title>
    <secondary-title>Urol. Oncol.-Semin. Orig. Investig</secondary-title>
  </titles>
  <doi>10.1016/J.UROLONC.2023.09.020</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2024</year>
    <pub-dates>
      <date>2024</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>